Abstract:Haidong Cheng, 1, * Gaowa Sharen, 2, * Zhaoyang Wang, 1 Jing Zhou 3 1 Department of Gastroenterology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010059, People's Republic of China; 2 Department of Pathological Anatomy, College of Basic Medicine of Inner Mongolia Medical University, Hohhot 010059, People's Republic of China; 3 Department of Pharmacology, College of Basic Medicine of Inner Mongolia Medical University, Hohhot 010059, People's Republic of China *These authors contributed equally to this work Correspondence: Zhaoyang Wang Department of Gastroenterology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010059, People's Republic of China Email wzydoc@126.com Jing Zhou Department of Pharmacology, College of Basic Medicine of Inner Mongolia Medical University, Hohhot 010059, People's Republic of China Email 591716788@qq.com Background: Chemoresistance contributes to treatment failure of gastric cancer (GC) patients but the molecular mechanism of chemoresistance in GC is still unclear. Long-chain noncoding RNA (lncRNA) urothelial cancer associated 1 ( UCA1 ) is associated with resistance to chemotherapy drugs. Methods: We detected the expression of UCA1 in 53 pairs of GC tumor tissue and adjacent normal tissue, human normal gastric mucosa cells (GES-1) and human GC cells (HGC-27, SNU-5, AGS, SGC-7901, and NCI-N87) using RT-qPCR. Small RNA interference technology was used to knock down the expression of UCA1 in gastric cancer cells. CCK8 solution was used to detect cell viability. Flow cytometry was used to detect apoptosis, and Western blotting was used to detect protein expression. Results: UCA1 was highly expressed in GC tissues and cells, and knockdown of UCA1 increased chemosensitivity to cisplatin by inducing cell apoptosis. Furthermore, UCA1 promoted CYP1B1 expression by binding to miR-513a-3p in human GC cells in vitro, and UCA1 / CYP1B1 expression was negatively related to miR-513a-3p expression, while UCA1 expression was positively related to CYP1B1 expression in human GC tissues. Moreover, overexpression of miR-513a-3p or knockdown of CYP1B1 increased chemosensitivity to cisplatin, and knockdown of miR-513a-3p or overexpression of CYP1B1 decreased chemosensitivity to cisplatin by inducing cell apoptosis in human GC cells. Importantly, overexpression of CYP1B1 reduced chemosensitivity to cisplatin which increased by knockdown of UCA1 , and knockdown of CYP1B1 increased chemosensitivity to cisplatin which decreased by knockdown of miR-513a-3p in human GC cells. Conclusion: The lncRNA UCA1 / miR-513a-3p / CYP1B1 axis regulates cisplatin resistance in human GC cells; hence, it is a potential target for treating chemoresistance in GC. Keywords: gastric cancer, urothelial cancer associated 1, chemoresistance

Long non-coding RNA UCA1 promotes glutamine metabolism by targeting miR-16 in human bladder cancer

Long noncoding RNA UCA1 promotes glutamine-driven anaplerosis of bladder cancer by interacting with hnRNP I/L to upregulate GPT2 expression

LncRNA UCA1 Promotes Mitochondrial Function of Bladder Cancer via the MiR-195/ARL2 Signaling Pathway.

Mir-1-3p Contributes to Cell Proliferation and Invasion by Targeting Glutaminase in Bladder Cancer Cells

Long Non-Coding RNA UCA1 Promotes Lung Cancer Cell Proliferation and Migration Via Microrna-193A/hmgb1 Axis.

LncRNA UCA1 Participates in De Novo Synthesis of Guanine Nucleotides in Bladder Cancer by Recruiting TWIST1 to Increase IMPDH1/2

Long Non-Coding RNA UCA1 Promotes Glycolysis by Upregulating Hexokinase 2 Through the Mtor-Stat3/microrna143 Pathway.

Hsa-miR-1 Downregulates Long Non-Coding RNA Urothelial Cancer Associated 1 in Bladder Cancer.

The common region of lncRNAs <i>UCA1</i> and <i>UCA1</i> contributes to the bladder cancer tumorigenesis

Deciphering glutamine metabolism patterns for malignancy and tumor microenvironment in clear cell renal cell carcinoma

MAFG‐AS1 promotes tumor progression via regulation of the HuR/PTBP1 axis in bladder urothelial carcinoma

Long noncoding RNA UCA1 inhibits epirubicin-induced apoptosis by activating PPARα-mediated lipid metabolism

MicroRNA-218 Increases the Sensitivity of Bladder Cancer to Cisplatin by Targeting Glut1

Gene Expression Profiling of Micrornas Associated with UCA1 in Bladder Cancer Cells.

UCA1 involved in the metformin-regulated bladder cancer cell proliferation and glycolysis

LncRNA UCA1 Promotes the Invasion and EMT of Bladder Cancer Cells by Regulating the Mir-143/Hmgb1 Pathway.

The lncRNA UCA1 interacts with miR-182 to modulate glioma proliferation and migration by targeting iASPP

Upregulation of long non-coding RNA urothelial carcinoma associated 1 by CCAAT/enhancer binding protein α contributes to bladder cancer cell growth and reduced apoptosis.

Long Non-Coding RNA UCA1 Promotes Cisplatin/gemcitabine Resistance Through CREB Modulating Mir-196A-5p in Bladder Cancer Cells.

LncRNA UCA1 Enhances Cisplatin Resistance by Regulating CYP1B1-mediated Apoptosis via miR-513a-3p in Human Gastric Cancer

LincRNA-p21 Suppresses Glutamine Catabolism and Bladder Cancer Cell Growth Through Inhibiting Glutaminase Expression.